105 related articles for article (PubMed ID: 9342123)
1. Effect of microsphere size distribution on the ultrasonographic contrast efficacy of air-filled albumin microspheres in the left ventricle of dog hearts.
Sontum PC; Walday P; Dyrstad K; Hoff L; Frigstad S; Chistiansen C
Invest Radiol; 1997 Oct; 32(10):627-35. PubMed ID: 9342123
[TBL] [Abstract][Full Text] [Related]
2. Physical and biochemical characterization of Albunex, a new ultrasound contrast agent consisting of air-filled albumin microspheres suspended in a solution of human albumin.
Christiansen C; Kryvi H; Sontum PC; Skotland T
Biotechnol Appl Biochem; 1994 Jun; 19(3):307-20. PubMed ID: 8031506
[TBL] [Abstract][Full Text] [Related]
3. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial.
Cohen JL; Cheirif J; Segar DS; Gillam LD; Gottdiener JS; Hausnerova E; Bruns DE
J Am Coll Cardiol; 1998 Sep; 32(3):746-52. PubMed ID: 9741522
[TBL] [Abstract][Full Text] [Related]
4. Optimization of the size distribution and myocardial contrast effect of perfluorocarbon-filled albumin microbubbles by lyophilization under continuous negative pressure.
Chen S; Wang Z; Zhou YT; Grayburn PA
J Am Soc Echocardiogr; 2000 Aug; 13(8):748-53. PubMed ID: 10936818
[TBL] [Abstract][Full Text] [Related]
5. Relationship between size of injected microspheres and ultrasound imaging of heart by PLSR.
Dyrstad K; Sontum PC
Pharm Res; 1997 Oct; 14(10):1485-9. PubMed ID: 9358566
[TBL] [Abstract][Full Text] [Related]
6. Differing susceptibility of echocardiographic contrast agents to adverse effects of biologic factors: multicenter, videodensitometric comparison of octafluoropropane-filled microspheres with air-filled microspheres for left ventricular opacification.
Hausnerova E; Gottdiener JS; Gould JJ; Pezzullo JC; Callahan JD; Cohen JL; Bruns DE; Kuvelas MT; West HE; Dittrich HC
J Am Soc Echocardiogr; 1999 Nov; 12(11):957-66. PubMed ID: 10552357
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy of two air-based contrast agents in dogs.
Uchimoto R; Niwa K; Tsuda N; Miyazawa T; Bräutigam M
Eur J Ultrasound; 2000 May; 11(2):127-33. PubMed ID: 10781661
[TBL] [Abstract][Full Text] [Related]
8. The influence of intravenous Albunex injections on pulmonary arterial pressure, gas exchange, and left ventricular peak intensity.
Walker R; Wiencek JG; Aronson S; Zaroff J; Glock D; Thisted R; Feinstein SB
J Am Soc Echocardiogr; 1992; 5(5):463-70. PubMed ID: 1389214
[TBL] [Abstract][Full Text] [Related]
9. Intracoronary air-filled albumin microspheres for myocardial blood flow measurement.
Rovai D; Ghelardini G; Trivella MG; Björklund G; Nevola E; Taddei L; Distante A; L'Abbate A
J Am Coll Cardiol; 1993 Dec; 22(7):2014-21. PubMed ID: 8245361
[TBL] [Abstract][Full Text] [Related]
10. Lack of an immune response to Albunex, a new ultrasound contrast agent based on air-filled albumin microspheres.
Christiansen C; Vebner AJ; Muan B; Vik H; Haider T; Nicolaysen H; Skotland T
Int Arch Allergy Immunol; 1994 Aug; 104(4):372-8. PubMed ID: 8038616
[TBL] [Abstract][Full Text] [Related]
11. Inhaled gases affect the ultrasound contrast produced by Albunex in anesthetized dogs.
Wible JH; Wojdyla JK; Bales GL; McMullen WN; Geiser EA; Buss DD
J Am Soc Echocardiogr; 1996; 9(4):442-51. PubMed ID: 8827627
[TBL] [Abstract][Full Text] [Related]
12. Effects of inhaled gases on the ultrasound contrast produced by microspheres containing air or perfluoropropane in anesthetized dogs.
Wible J; Wojdyla J; Bugaj J; Brandenburger G
Invest Radiol; 1998 Dec; 33(12):871-9. PubMed ID: 9851821
[TBL] [Abstract][Full Text] [Related]
13. Absorption and scatter of encapsulated gas filled microspheres: theoretical considerations and some measurements.
de Jong N; Hoff L; Skotland T; Bom N
Ultrasonics; 1992 Mar; 30(2):95-103. PubMed ID: 1557838
[TBL] [Abstract][Full Text] [Related]
14. Acoustic properties of NC100100 and their relation with the microbubble size distribution.
Sontum PC; Ostensen J; Dyrstad K; Hoff L
Invest Radiol; 1999 Apr; 34(4):268-75. PubMed ID: 10196718
[TBL] [Abstract][Full Text] [Related]
15. Physical and biochemical stability of Optison, an injectable ultrasound contrast agent.
Podell S; Burrascano C; Gaal M; Golec B; Maniquis J; Mehlhaff P
Biotechnol Appl Biochem; 1999 Dec; 30(3):213-23. PubMed ID: 10574690
[TBL] [Abstract][Full Text] [Related]
16. Precision and accuracy of analysis of air-filled albumin microspheres using Coulter Multisizer Mark II.
Sontum PC; Christiansen C
J Pharm Biomed Anal; 1994 Oct; 12(10):1233-41. PubMed ID: 7841217
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
[TBL] [Abstract][Full Text] [Related]
18. Quantification of transpulmonary echocontrast effects.
de Jong N; ten Cate FJ; Vletter WB; Roelandt JR
Ultrasound Med Biol; 1993; 19(4):279-88. PubMed ID: 8346602
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound scattering properties of Albunex microspheres.
de Jong N; Hoff L
Ultrasonics; 1993; 31(3):175-81. PubMed ID: 8484195
[TBL] [Abstract][Full Text] [Related]
20. The mechanism and clinical implication of improved left ventricular videointensity following intravenous injection of multi-fold dilutions of albumin with dextrose.
Porter TR; Xie F; Kricsfeld A
Int J Card Imaging; 1995 Jun; 11(2):117-25. PubMed ID: 7673759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
